Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Annual Review of Genomics and Human Genetics
|
April 30, 2014
Therapeutics based on stop codon readthrough
Kim M Keeling, Xiaojiao Xue, Gwen Gunn, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications
|
August 10, 2010
Cloning, purification, crystallization and preliminary crystallographic analysis of the tandem tudor domain of Sgf29 from Saccharomyces cerevisiae
Jing Li, Xiaojiao Xue, Jianbin Ruan, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
July 20, 2022
Ataluren suppresses a premature termination codon in an MPS I-H mouse
Dan Wang, Xiaojiao Xue, Gwen Gunn, et al.
Human Molecular Genetics
|
June 3, 2017
Identification of the amino acids inserted during suppression of CFTR nonsense mutations and determination of their functional consequences
Xiaojiao Xue, Venkateshwar Mutyam, Amita Thakerar, et al.
American Journal of Respiratory Cell and Molecular Biology
|
November 21, 2013
Synthetic aminoglycosides efficiently suppress cystic fibrosis transmembrane conductance regulator nonsense mutations and are enhanced by ivacaftor
Xiaojiao Xue, Venkateshwar Mutyam, Liping Tang, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 23, 2022
Guanidino quinazolines and pyrimidines promote readthrough of premature termination codons in cells with native nonsense mutations
Christie Morrill, Westley J Friesen, Suresh Babu, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 6, 2016
Ataluren stimulates ribosomal selection of near-cognate tRNAs to promote nonsense suppression
Bijoyita Roy, Westley J Friesen, Yuki Tomizawa, et al.
American Journal of Respiratory and Critical Care Medicine
|
April 23, 2016
Discovery of Clinically Approved Agents That Promote Suppression of Cystic Fibrosis Transmembrane Conductance Regulator Nonsense Mutations
Venkateshwar Mutyam, Ming Du, Xiaojiao Xue, et al.
Plos One
|
October 26, 2018
The minor gentamicin complex component, X2, is a potent premature stop codon readthrough molecule with therapeutic potential
Westley J Friesen, Briana Johnson, Jairo Sierra, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Annual Review of Genomics and Human Genetics
|
April 30, 2014
Therapeutics based on stop codon readthrough
Kim M Keeling, Xiaojiao Xue, Gwen Gunn, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications
|
August 10, 2010
Cloning, purification, crystallization and preliminary crystallographic analysis of the tandem tudor domain of Sgf29 from Saccharomyces cerevisiae
Jing Li, Xiaojiao Xue, Jianbin Ruan, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
July 20, 2022
Ataluren suppresses a premature termination codon in an MPS I-H mouse
Dan Wang, Xiaojiao Xue, Gwen Gunn, et al.
Human Molecular Genetics
|
June 3, 2017
Identification of the amino acids inserted during suppression of CFTR nonsense mutations and determination of their functional consequences
Xiaojiao Xue, Venkateshwar Mutyam, Amita Thakerar, et al.
American Journal of Respiratory Cell and Molecular Biology
|
November 21, 2013
Synthetic aminoglycosides efficiently suppress cystic fibrosis transmembrane conductance regulator nonsense mutations and are enhanced by ivacaftor
Xiaojiao Xue, Venkateshwar Mutyam, Liping Tang, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 23, 2022
Guanidino quinazolines and pyrimidines promote readthrough of premature termination codons in cells with native nonsense mutations
Christie Morrill, Westley J Friesen, Suresh Babu, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 6, 2016
Ataluren stimulates ribosomal selection of near-cognate tRNAs to promote nonsense suppression
Bijoyita Roy, Westley J Friesen, Yuki Tomizawa, et al.
American Journal of Respiratory and Critical Care Medicine
|
April 23, 2016
Discovery of Clinically Approved Agents That Promote Suppression of Cystic Fibrosis Transmembrane Conductance Regulator Nonsense Mutations
Venkateshwar Mutyam, Ming Du, Xiaojiao Xue, et al.
Plos One
|
October 26, 2018
The minor gentamicin complex component, X2, is a potent premature stop codon readthrough molecule with therapeutic potential
Westley J Friesen, Briana Johnson, Jairo Sierra, et al.
Page
of 1